Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2010
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718575 Method of selecting HLA-DP4 ligands and the applications thereof
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718178 Allergen formulation
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/14/2010WO2010054321A2 Methods of treating autoimmune disorders and/or inflammatory disorders
05/14/2010WO2010054267A1 Immunosuppression compound and treatment method
05/14/2010WO2010054126A2 Small molecule modulators of epigenetic regulation and their therapeutic applications
05/14/2010WO2010054058A1 Imidazolothiazole compounds as modulators of protein kinase
05/14/2010WO2010054024A2 Novel compounds as cannabinoid receptor ligands
05/14/2010WO2010053902A2 Tryptase enzyme inhibiting aminothiophenols
05/14/2010WO2010053751A1 High affinity human antibodies to human il-4 receptor
05/14/2010WO2010053433A1 Increased expression of specific antigens
05/14/2010WO2010053316A2 New use of sixth immunoglobulin-like domain of vcam-1
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010WO2010051635A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010WO2010051634A1 Human progenitor t-cells
05/14/2010WO2010027189A9 A new use for homoisoflavanone or a salt thereof
05/14/2010WO2010025267A3 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
05/14/2010WO2009153434A3 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
05/14/2010WO2009151496A4 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
05/14/2010CA2778435A1 Vaccines targeting cellular death receptors
05/14/2010CA2746054A1 Small molecule modulators of epigenetic regulation and their therapeutic applications
05/14/2010CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010CA2742808A1 Mesothelin antibody protein fusions and methods of use
05/14/2010CA2742777A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010CA2742622A1 Human progenitor t-cells
05/14/2010CA2742517A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010CA2742281A1 Immunosuppression compound and treatment method
05/14/2010CA2741047A1 Novel compounds as cannabinoid receptor ligands
05/14/2010CA2737044A1 High affinity human antibodies to human il-4 receptor
05/13/2010US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/13/2010US20100120869 Compounds and methods for pkc theta inhibition
05/13/2010US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
05/13/2010US20100120844 Tetrahydroisoquinoline compound
05/13/2010US20100120840 tyrosine kinase inhibitors such as 1-Phenyl-ethyl)-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-amine, used in the prevention and therapy of transplant rejection, inflammatory bowel disease, arthritis, psoriasis, restenosis, asthma, stroke, osteoporosis, cancer, Alzheimer's and Parkinson's disease
05/13/2010US20100120839 Pyrazoles useful in the treatment of inflammation
05/13/2010US20100120831 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial
05/13/2010US20100120828 Method of inducing interferon biosynthesis
05/13/2010US20100120822 Method of controlling formation of imiquimod impurities (bha comparator)
05/13/2010US20100120819 Method of reducing imiquimod impurity formation
05/13/2010US20100120808 Spirocyclic heterocyclic derivatives and methods of their use
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120732 Agent for prevention and/or treatment of systemic lupus erythematosus
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120719 Lyophilization formulation
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof
05/13/2010US20100120070 Precise efficacy assay methods for active agents including chemotherapeutic agents
05/13/2010US20100119594 Nourin and nourin antagonists
05/13/2010US20100119586 Patch for Cutaneous Application
05/13/2010US20100119570 Solid Pharmaceutical And Vaccine Dose
05/13/2010US20100119556 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119552 Purification of vaccinia viruses using hydrophobic interaction chromatography
05/13/2010US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response
05/13/2010US20100119550 Recombinant multivalent vaccine
05/13/2010US20100119549 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
05/13/2010US20100119548 Injecting directly into a tumor; cancer vaccine
05/13/2010US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines
05/13/2010US20100119545 Modified vaccinia ankara virus variant
05/13/2010US20100119544 Vaccine
05/13/2010US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
05/13/2010US20100119531 Nutriceutical gels
05/13/2010US20100119524 Adjuvanted vaccine
05/13/2010US20100119506 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation
05/13/2010US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/13/2010US20100119484 Derivatisation of biological molecules
05/13/2010US20100119483 Peptide viral entry inhibitors
05/13/2010US20100119480 Methods for treating multiple sclerosis using antisense oligonucleotides
05/13/2010US20100119471 Mycoplasma hyopneumoniae bacterin vaccine
05/12/2010EP2184355A1 Antibody modified with hydrophobic molecule
05/12/2010EP2184298A1 Antibodies against human IL-21 receptor and uses therefor
05/12/2010EP2184085A1 Treatment of diseases
05/12/2010EP2184070A1 HLA-G proteins and pharmaceutical uses thereof
05/12/2010EP2183366A1 Immunogenic polypeptides and monoclonal antibodies
05/12/2010EP2183028A2 Targeted binging agents directed to kdr and uses thereof - 035
05/12/2010EP2182987A1 Immune system modulator formulation
05/12/2010EP2182940A1 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease
05/12/2010EP2182922A1 Antigen-adjuvant compositions and methods
05/12/2010EP2182808A1 Pyridine compounds for inflammation and immune-related uses
05/12/2010EP1828113B1 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
05/12/2010CN1965813B Compound soft capsule of propolis
05/12/2010CN1957956B Composition having multiple fungus possessing effects of anti tumour and adjusting immunity, preparation method, and usage thereof
05/12/2010CN1951430B Compound Chinese medicine for treating psoriasis and lupus erythematosus
05/12/2010CN1944463B Fusion protein with alpha-interferon activity and its coded gene and use
05/12/2010CN1929850B Purified polyoxypropylene/polyoxyethylene copolymers and method of preparing the same
05/12/2010CN1915050B Ganoderma lucidum tea and processing technique
05/12/2010CN1907328B Kuh-seng gel formulation and its preparing process
1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 1172